Abstract: . . .  Blom, HJ, Gerritis, WBJ, Rosendaal, FR, Haak, HL, Wijermans, PW, Bos, GMJ. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis ? Lancet. 1995; 345: 882-885. 15. Ridker, PM, Hennekens, CH, Selhub, J, Miletich, JP, Mlnow, MR, Stampfer, MJ. Interrelation of hyperhomocysteinemia, factor V Leiden, and risk of future venous thromboembolism. Circulation. 1997; 95: 1777-1782. 16. Sirrs, S, Duncan, L, Ognjenka, D, Nussbaumer, G, Ganz, G, Frohlich, J, Levin, A. Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. Nephrol Dial Transplant 1999; 14: 738- 743. 17. Bowden, RG, Wyatt, F, Wilson, R. Homocysteine and Vascular Access Thrombosis in End-Stage Renal Disease Patients: A Retrospective Study. J Nephrol, 2003 (In Press). 18. Kes, P. Hyperhomocysteinemia in end-stage renal failure. Acta Med. Croat. 2000; 53(4-5): 175-181. 19. McCully, KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969; 56: 111-118. 20. Qur I; Perneger TV; Zittoun J; Bellet H; Gris JC; Daurs JP; Schved JF; Mercier E; Laroche JP; Dauzat M; Bounameaux H; Janbon C; de Moerloose P. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet, 2002 Mar 2; 359 (9308): 747 -52. 21. Ifudu, O, Macey, LJ, Homel, P, Hyppolite, . . .
. . .  10. Finkelstein, JD. Regulation of Homocysteine Metabolism. Homocysteine in Health and Disease. New York. Cambridge Page 4 University Press, 2001; 92-99. 11. Schmitz, PG, McCloud, LK, Reikes, ST, Leonard, CL, and Gellens, ME. Prophylaxis of hemodialysis graft thrombosis with fish oil; Double-blind, Randomized, prospective trial. J Am Soc Nephrol. 2002; 13: 184-190. 12. Tamura, T, Bergman, SM, Morgan, SL. Homocysteine, B vitamins, and vascular-access thrombosis in patients treated with hemodialysis. Am J Kidney Dis 1998; 32(3): 475-481. 13. Fermo, I, D'Angelo, SV, Paroni, R, Mazzola, G, Calori, G, D'Angelo, A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Am J Kidney Dis 1995; 22: 215 -225. 14. van Heijer, M, Koster, T, Blom, HJ, Gerritis, WBJ, Rosendaal, FR, Haak, HL, Wijermans, PW, Bos, GMJ. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis ? Lancet. 1995; 345: 882-885. 15. Ridker, PM, Hennekens, CH, Selhub, J, Miletich, JP, Mlnow, MR, Stampfer, MJ. Interrelation of hyperhomocysteinemia, factor V Leiden, and risk of future venous thromboembolism. Circulation. 1997; 95: 1777-1782. 16. Sirrs, S, Duncan, L, Ognjenka, D, Nussbaumer, G, Ganz, G, Frohlich, J, Levin, A. Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. . . .
--3000,2,750,3158,20424